- Home
- ALLO vs TIPT Comparison
ALLO vs TIPT Comparison
Compare ALLO & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | TIPT |
|---|---|---|
| Founded | 2017 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.4M | 651.9M |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ALLO | TIPT |
|---|---|---|
| Price | $2.17 | $18.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $8.35 | N/A |
| AVG Volume (30 Days) | ★ 6.1M | 227.0K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 1.40% |
| EPS Growth | ★ 34.09 | N/A |
| EPS | N/A | ★ 0.34 |
| Revenue | N/A | ★ $488,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $142,416.42 | N/A |
| P/E Ratio | ★ N/A | $51.34 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.99 | $15.49 |
| 52 Week High | $4.46 | $27.38 |
Technical Indicators
Market Signals| Indicator | ALLO | TIPT |
|---|---|---|
| Relative Strength Index (RSI) | 48.92 | 68.08 |
| Support Level | $2.12 | $18.11 |
| Resistance Level | $2.71 | $18.71 |
| Average True Range (ATR) | 0.14 | 0.41 |
| MACD | 0.02 | 0.11 |
| Stochastic Oscillator | 57.27 | 97.81 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.